
What We're Reading: Long-term COVID-19; Intellectual Disability, Coronavirus Death; Pfizer Vaccine Neutralizes Brazil Variant
Many people who experience long-term symptoms from COVID-19 were asymptomatic when initially infected; COVID-19 patients with intellectual disabilities were shown to be more susceptible to hospitalization and death; the Pfizer/BioNTech vaccine neutralizes the more contagious variant first identified in Brazil.
Lingering COVID-19 Symptoms More Likely in Initially Asymptomatic People
Reported by
Intellectual Disability Second Only to Old Age for Risk of COVID-19 Death
Patients with intellectual disabilities were shown to be more susceptible to COVID-19 hospitalization, intensive care unit admission, and death compared with those without these limitations. Reported by
Pfizer/BioNTech Vaccine Shown to Neutralize Brazil Variant
The coronavirus vaccine manufactured by Pfizer/BioNTech was shown to neutralize a
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.